Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights

Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights

BackgroundWe investigated the association between serum MUC5AC (sMUC5AC) levels and patient outcomes in individuals who underwent resection for pancreatic ductal adenocarcinoma (PDA), including those treated with neoadjuvant therapy (NAT) and those who had upfront surgery (UpS) followed by adjuvant...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashish Manne, Yonghua Bao, Ankur Sheel, Amir Sara, Upender Manne, Kannan Thanikachalam, Ashwini Esnakula, Timothy M. Pawlik, Jordan M. Cloyd, Susan Tsai, Anup Kasi, Ravi Kumar Paluri, Deepak Sherpally, Sravan Jeepalyam, Lianbo Yu, Wancai Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Oncology
Subjects:
pancreatic cancer
MUC5AC
biomarker
predicting
neoadjuvant therapy
FOLFIRINOX
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1544928/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1544928/full

Similar Items